BioSig Technologies, Inc.
NASDAQ Capital MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- BioSig Technologies, Inc. (NASDAQ: BSGM) develops advanced digital signal processing technology for cardiac electrophysiology procedures. The company offers the PURE EP Platform, an FDA 510(k)-cleared, non-invasive Class II medical device that provides real-time, high-fidelity intracardiac signal visualization to electrophysiologists performing ablation treatments for cardiovascular arrhythmias, including atrial fibrillation; the platform integrates hardware and software for enhanced signal clarity, artifact reduction, and procedural efficiency in electrophysiology labs. Founded in 2009 and headquartered in Westport, Connecticut, BioSig Technologies targets healthcare institutions, hospitals, and cardiac centers primarily in the United States, with operations focused on research, development, clinical validation, regulatory compliance, and commercialization in the electrophysiology segment of the medical device industry. In recent developments, the company completed a merger with Streamex Exchange Corporation in 2025 through a share exchange agreement, making Streamex a wholly owned subsidiary specializing in real-world asset tokenization for commodities markets, particularly gold; announced a corporate rebrand to Streamex Corp. effective September 12, 2025, with a new ticker symbol STEX on Nasdaq Capital Market; and secured definitive agreements for up to $1.1 billion in growth financing from an institutional investor to support expansion into regulated, yield-bearing financial products powered by tokenization infrastructure.
Streamex Corp., NASDAQ: STEX & Simplify Asset Management $10 billion USD AUM ETF Manager Announces Letter of Intent Pursuing a Strategic Partnership to Drive ETF Innovation through Integration of Tokenized Gold Yield Assets and Tokenization of Existing ETFs
Streamex Corp., NASDAQ: STEX & Simplify Asset Management $10 billion USD AUM ETF Manager Announces Letter of Intent Pursuing a Strategic Partnership to Drive ETF Innovation through Integration of Tokenized Gold Yield Assets and Tokenization of Existing ETFs
BioSig Technologies, Inc. Announces Corporate Rebrand to Streamex Corp.
BioSig Technologies Supplements Clarification on Recent Schedule 14A Filing. Closing of Merger with Streamex Exchange Corporation Not Affected
Streamex (BSGM) to Participate in the 5th Annual Needham Virtual Crypto 1x1 Conference on September 4th
BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering
BioSig Technologies Inc. Announces Pricing of $15 Million Public Offering
BioSig Technologies Inc. Announces Proposed Public Offering
BIOSIG TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of BioSig Technologies, Inc. - BSGM
Here's 1 New Billion-Dollar Reason to Buy Solana And Never Look Back
CORRECTION: BioSig & Streamex Clarify and Correct Details of Russell Starr's Appointment and Biography
BSGM Engages CXG to Acquire FINRA/SEC-Registered Broker-Dealer to Expand Publicly Traded RWA Tokenization Operations
CORRECTING and REPLACING BioSig & Streamex Appoint Defi Expert and Visionary, Russell Starr as Strategic Advisor
BioSig & Streamex Appoint Defi Expert and Visionary, Russell Starr as Strategic Advisor
BioSig & Streamex Appoint Parcl Co-Founders Trevor Bacon and Kellan Grenier as Strategic Advisors
BioSig & Streamex Appoint Co-Founder of the Osisko Group & Mining Visionary, Sean Roosen as Strategic Advisor
BIOSIG TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of BioSig Technologies, Inc. - BSGM
CORRECTION: Streamex and BioSig Appoint Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (CIO)
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of BioSig Technologies, Inc. (NASDAQ: BSGM)
BioSig Appoints Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer